FDA Warns Against Use Of Decorative Contact Lenses.

The Los Angeles Times Share to FacebookShare to Twitter (10/25, Kaplan) “Science Now” blog reports that for individuals who intend to wear decorative contact lenses as part of a Halloween costume this year, “the Food and Drug Administration has a warning for you: Make sure you get a prescription from an optometrist or other eye care professional.” In a video on the Times’ website, Dr. James Saviola, an optometrist and FDA eye safety expert, says, “The problem isn’t with the decorative contact lenses themselves,” but with their improper use. Meanwhile, in a “Consumer Update.” FDA optometrist Dr. Bernard Lepri said, “Bacterial infections can be extremely rapid, result in corneal ulcers, and cause blindness – sometimes within as little as 24 hours if not diagnosed and treated promptly.”

On its website, CBS News Share to FacebookShare to Twitter (10/25, Castillo) reports that the agency “said that people should never buy color contact lenses from street vendors, salons or beauty supply stores, boutiques, flea markets, novelty stores, Halloween stores, record or video stores, convenience shops, beach shops or the Internet, unless the site requires a prescription.”

McClatchy Share to FacebookShare to Twitter (10/24, Hotakainen) reports on “‘Operation Double Vision,’ an effort to stop the flow of illegally imported decorative lenses and counterfeit contact lenses that appeal to kids at Halloween.” The FDA is participating in the effort.

FOX News Share to FacebookShare to Twitter (10/24) cites John Roth, director of FDA’s Office of Criminal Investigations, who stated, “Our concern is that consumers who buy and use decorative contact lenses without a valid prescription can run significant risks of eye injuries, including blindness. ... It is always better to involve a qualified eye care professional and protect your vision.” Also covering the story are the Syracuse (NY) Post-Standard Share to FacebookShare to
Twitter (10/25, Mulder), Alabama Live Share to FacebookShare to Twitter (10/25), HealthDay Share to FacebookShare to Twitter (10/25, Preidt).